1H07 | pdb_00001h07

CDK2 in complex with a disubstituted 4, 6-bis anilino pyrimidine CDK4 inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free: 
    0.235 (Depositor), 0.232 (DCC) 
  • R-Value Work: 
    0.210 (Depositor), 0.210 (DCC) 

wwPDB Validation 3D Report Full Report

Validation slider image for 1H07

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Cyclin-Dependent Kinase 4 Inhibitors as a Treatment for Cancer. Part 1: Identification and Optimisation of Substituted 4,6-Bis Anilino Pyrimidines

Beattie, J.F.Breault, G.A.Ellston, R.P.A.Green, S.Jewsbury, P.J.Midgley, C.J.Naven, R.T.Minshull, C.A.Pauptit, R.A.Tucker, J.A.Pease, J.E.

(2003) Bioorg Med Chem Lett 13: 2955

  • DOI: https://doi.org/10.1016/s0960-894x(03)00202-6
  • Primary Citation Related Structures: 
    1H00, 1H01, 1H07, 1H08, 1V1K

  • PubMed Abstract: 

    Using a high-throughput screening campaign, we identified the 4,6-bis anilino pyrimidines as inhibitors of the cyclin-dependent kinase, CDK4. Herein we describe the further chemical modification and use of X-ray crystallography to develop potent and selective in vitro inhibitors of CDK4.


  • Organizational Affiliation
    • AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.

Macromolecule Content 

  • Total Structure Weight: 35.03 kDa 
  • Atom Count: 2,550 
  • Modeled Residue Count: 286 
  • Deposited Residue Count: 299 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
CELL DIVISION PROTEIN KINASE 2299Homo sapiensMutation(s): 0 
EC: 2.7.1.37 (PDB Primary Data), 2.7.11.22 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for P24941 (Homo sapiens)
Explore P24941 
Go to UniProtKB:  P24941
PHAROS:  P24941
GTEx:  ENSG00000123374 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP24941
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
MFP

Query on MFP



Download:Ideal Coordinates CCD File
B [auth A]((2-BROMO-4-METHYLPHENYL){6-[(4-{[(2R)-3-(DIMETHYLAMINO)-2-HYDROXYPROPYL]OXY}PHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)ACETONITRILE
C24 H27 Br N6 O2
UUISESFNPSRBFN-LJQANCHMSA-N
MFQ

Query on MFQ



Download:Ideal Coordinates CCD File
C [auth A]((2-BROMO-4-METHYLPHENYL){6-[(4-{[(2S)-3-(DIMETHYLAMINO)-2-HYDROXYPROPYL]OXY}PHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)ACETONITRILE
C24 H27 Br N6 O2
UUISESFNPSRBFN-IBGZPJMESA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
MFP BindingDB:  1H07 IC50: 3000 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free:  0.235 (Depositor), 0.232 (DCC) 
  • R-Value Work:  0.210 (Depositor), 0.210 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 53.323α = 90
b = 71.543β = 90
c = 72.55γ = 90
Software Package:
Software NamePurpose
CNXrefinement
MOSFLMdata reduction
SCALAdata scaling
AMoREphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2003-07-11
    Type: Initial release
  • Version 1.1: 2011-05-08
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2024-10-16
    Changes: Data collection, Database references, Derived calculations, Other, Structure summary